Literature DB >> 31078222

Pulmonary Hypertension and Exercise.

James R Vallerand1, Jason Weatherald2, Pierantonio Laveneziana3.   

Abstract

Cardiopulmonary exercise testing can be a useful tool for clinicians working with pulmonary hypertension (PH) patients. Exercise magnifies numerous cardiopulmonary decompensations, which can help inform diagnoses, assess degrees of physical impairment, evaluate exertional dyspnea, and estimate prognoses for PH patients. Supervised exercise training also holds promise in PH, because it is safe for patients and feasible and may improve key prognostic outcomes that relate to improvements in quality of life and survival. Still, few clinical trials have evaluated the potential therapeutic effects of exercise training, and future trials may benefit from integrating programming that focuses on light-intensity endurance, strength, and respiratory training.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiopulmonary exercise testing; Chronic thromboembolic pulmonary hypertension; Dyspnea; Pulmonary arterial hypertension; Pulmonary vascular disease

Mesh:

Year:  2019        PMID: 31078222     DOI: 10.1016/j.ccm.2019.02.003

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  2 in total

1.  The role of cardiopulmonary exercise testing and training in patients with pulmonary hypertension: making the case for this assessment and intervention to be considered a standard of care.

Authors:  Ahmad Sabbahi; Richard Severin; Cemal Ozemek; Shane A Phillips; Ross Arena
Journal:  Expert Rev Respir Med       Date:  2020-01-03       Impact factor: 3.772

2.  Effectiveness and safety of a simple home-based rehabilitation program in pulmonary arterial hypertension: an interventional pilot study.

Authors:  Mariusz Wojciuk; Mariusz Ciolkiewicz; Anna Kuryliszyn-Moskal; Sylwia Chwiesko-Minarowska; Emilia Sawicka; Katarzyna Ptaszynska-Kopczynska; Karol Kaminski
Journal:  BMC Sports Sci Med Rehabil       Date:  2021-07-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.